{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:16:43Z","timestamp":1790515003688,"version":"4.1.0"},"reference-count":35,"publisher":"American Society of Hematology","issue":"21","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The role of complement in the pathogenesis of venous thromboembolism (VTE) is unclear. We wanted to investigate (1) whether plasma complement component C5 (C5) levels are influenced by genetic variants or chronic inflammation and (2) the association between plasma C5 and risk of future VTE in a nested case-control study of 415 patients with VTE and 848 age- and sex-matched controls derived from the Troms\u00f8 Study. Plasma C5 levels were measured at inclusion. Odds ratios (ORs) with 95% confidence intervals (95% CIs) for provoked and unprovoked VTE across tertiles of C5 concentrations were estimated by logistic regression. Adjustment for C-reactive protein (CRP) served as a proxy for general inflammation. Whole-exome sequencing and protein quantitative trait loci analyses were performed to assess genetic influence on C5 concentrations. There was no association between genome-wide or C5-related gene variants and C5 levels. The association between plasma C5 levels and VTE risk displayed a threshold effect, where subjects with C5 levels above the lowest tertile had increased risk of VTE. Subjects in tertile 3 (highest C5 levels) had an age- and sex-adjusted OR of 1.45 (95% CI, 1.07-1.96) compared with tertile 1 (lowest). These statistics were more pronounced for unprovoked VTE (OR, 1.70; 95% CI, 1.11-2.60). Adjustments for body mass index and CRP had minor impact on risk estimates. The OR increased substantially with shorter time between blood sampling and VTE event. In conclusion, plasma C5 was associated with risk of future VTE. C5 levels were not genetically regulated and were only slightly influenced by chronic inflammation.<\/jats:p>","DOI":"10.1182\/blood.2021010822","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T18:54:33Z","timestamp":1627930473000},"page":"2129-2137","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":21,"title":["Elevated plasma concentration of complement factor C5 is associated with risk of future venous thromboembolism"],"prefix":"10.1182","volume":"138","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-082X","authenticated-orcid":false,"given":"Espen Waage","family":"Skjeflo","sequence":"first","affiliation":[{"name":"K. G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Troms\u00f8\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Research Laboratory, Nordland Hospital, Bod\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9678-9696","authenticated-orcid":false,"given":"Sigrid Kufaas","family":"Br\u00e6kkan","sequence":"additional","affiliation":[{"name":"K. G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Troms\u00f8\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Division of Internal Medicine, University Hospital of North Norway, Troms\u00f8, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith Krey","family":"Ludviksen","sequence":"additional","affiliation":[{"name":"Research Laboratory, Nordland Hospital, Bod\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omri","family":"Snir","sequence":"additional","affiliation":[{"name":"K. G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Troms\u00f8\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8194-6679","authenticated-orcid":false,"given":"Kristian","family":"Hindberg","sequence":"additional","affiliation":[{"name":"K. G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Troms\u00f8\u2013The Arctic University of Norway, Troms\u00f8, Norway;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom Eirik","family":"Mollnes","sequence":"additional","affiliation":[{"name":"K. G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Troms\u00f8\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Research Laboratory, Nordland Hospital, Bod\u00f8, Norway;"},{"name":"Department of Immunology, Oslo University Hospital, University of Oslo, Oslo, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-Bjarne","family":"Hansen","sequence":"additional","affiliation":[{"name":"K. G. Jebsen Thrombosis Research and Expertise Center (TREC), Department of Clinical Medicine, University of Troms\u00f8\u2013The Arctic University of Norway, Troms\u00f8, Norway;"},{"name":"Division of Internal Medicine, University Hospital of North Norway, Troms\u00f8, Norway; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"2","key":"2021112516212957200_B1","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/jth.13587","article-title":"Recurrence and mortality after first venous thromboembolism in a large population-based cohort","volume":"15","author":"Arshad","year":"2017","journal-title":"J Thromb Haemost."},{"issue":"1","key":"2021112516212957200_B2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med."},{"key":"2021112516212957200_B3","doi-asserted-by":"crossref","first-page":"15006","DOI":"10.1038\/nrdp.2015.6","article-title":"Venous thrombosis","volume":"1","author":"Wolberg","year":"2015","journal-title":"Nat Rev Dis Primer."},{"issue":"7","key":"2021112516212957200_B4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI60229","article-title":"New insights into the mechanisms of venous thrombosis","volume":"122","author":"Mackman","year":"2012","journal-title":"J Clin Invest."},{"issue":"9","key":"2021112516212957200_B5","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross talk pathways between coagulation and inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res."},{"issue":"1","key":"2021112516212957200_B6","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/imr.12471","article-title":"Dangerous liaisons: complement, coagulation, and kallikrein\/kinin cross-talk act as a linchpin in the events leading to thromboinflammation","volume":"274","author":"Ekdahl","year":"2016","journal-title":"Immunol Rev."},{"issue":"3","key":"2021112516212957200_B7","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1373\/clinchem.2015.251314","article-title":"Complement C3 and high risk of venous thromboembolism: 80517 individuals from the Copenhagen General Population Study","volume":"62","author":"N\u00f8rgaard","year":"2016","journal-title":"Clin Chem."},{"issue":"6","key":"2021112516212957200_B8","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/jth.14438","article-title":"Complement activation assessed by the plasma terminal complement complex and future risk of venous thromboembolism","volume":"17","author":"H\u00f8iland","year":"2019","journal-title":"J Thromb Haemost."},{"issue":"10","key":"2021112516212957200_B9","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1111\/jth.14539","article-title":"Plasma levels of mannose-binding lectin and future risk of venous thromboembolism","volume":"17","author":"Liang","year":"2019","journal-title":"J Thromb Haemost."},{"key":"2021112516212957200_B10","first-page":"1","article-title":"The complement system: an overview","volume":"150","author":"Morgan","year":"2000","journal-title":"Methods Mol Biol."},{"issue":"1","key":"2021112516212957200_B11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/bjh.12347","article-title":"Long-term safety and efficacy of sustained eculizumab treatment in patients with paroxysmal nocturnal haemoglobinuria","volume":"162","author":"Hillmen","year":"2013","journal-title":"Br J Haematol."},{"issue":"6","key":"2021112516212957200_B12","first-page":"2019","article-title":"Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation","volume":"150","author":"Kilgore","year":"1997","journal-title":"Am J Pathol."},{"issue":"24","key":"2021112516212957200_B13","doi-asserted-by":"crossref","first-page":"11907","DOI":"10.1016\/S0021-9258(18)37872-4","article-title":"Complement proteins C5b-9 initiate secretion of platelet storage granules without increased binding of fibrinogen or von Willebrand factor to newly expressed cell surface GPIIb-IIIa","volume":"263","author":"Ando","year":"1988","journal-title":"J Biol Chem."},{"issue":"4","key":"2021112516212957200_B14","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1182\/blood.V68.4.875.875","article-title":"Complement proteins C5b-9 stimulate procoagulant activity through platelet prothrombinase","volume":"68","author":"Wiedmer","year":"1986","journal-title":"Blood."},{"issue":"34","key":"2021112516212957200_B15","doi-asserted-by":"crossref","first-page":"18205","DOI":"10.1016\/S0021-9258(19)81346-7","article-title":"Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity","volume":"263","author":"Sims","year":"1988","journal-title":"J Biol Chem."},{"issue":"9","key":"2021112516212957200_B16","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J Exp Med."},{"issue":"15","key":"2021112516212957200_B17","doi-asserted-by":"crossref","first-page":"9053","DOI":"10.1016\/S0021-9258(18)81901-9","article-title":"Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface","volume":"264","author":"Hattori","year":"1989","journal-title":"J Biol Chem."},{"issue":"2","key":"2021112516212957200_B18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/s-0038-1655974","article-title":"C5a induces tissue factor activity on endothelial cells","volume":"77","author":"Ikeda","year":"1997","journal-title":"Thromb Haemost."},{"issue":"1","key":"2021112516212957200_B19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/cei.13240","article-title":"Complement component 5 does not interfere with physiological hemostasis but is essential for Escherichia coli-induced coagulation accompanied by Toll-like receptor 4","volume":"196","author":"Landsem","year":"2019","journal-title":"Clin Exp Immunol."},{"issue":"16","key":"2021112516212957200_B20","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1182\/blood-2016-11-749879","article-title":"Distinct contributions of complement factors to platelet activation and fibrin formation in venous thrombus development","volume":"129","author":"Subramaniam","year":"2017","journal-title":"Blood."},{"issue":"4","key":"2021112516212957200_B21","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1093\/ije\/dyr049","article-title":"Cohort profile: the Tromso Study","volume":"41","author":"Jacobsen","year":"2012","journal-title":"Int J Epidemiol."},{"issue":"10","key":"2021112516212957200_B22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/aje\/kwq066","article-title":"Body height and risk of venous thromboembolism: the Troms\u00f8 Study","volume":"171","author":"Braekkan","year":"2010","journal-title":"Am J Epidemiol."},{"issue":"1","key":"2021112516212957200_B23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1471-2105-15-125","article-title":"Effective filtering strategies to improve data quality from population-based whole exome sequencing studies","volume":"15","author":"Carson","year":"2014","journal-title":"BMC Bioinformatics."},{"issue":"4","key":"2021112516212957200_B24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCGENETICS.115.001327","article-title":"Associations between common and rare exonic genetic variants and serum levels of 20 cardiovascular-related proteins: the Troms\u00f8 Study","volume":"9","author":"Solomon","year":"2016","journal-title":"Circ Cardiovasc Genet."},{"issue":"2","key":"2021112516212957200_B25","doi-asserted-by":"crossref","first-page":"c2289","DOI":"10.1136\/bmj.c2289","article-title":"Random measurement error and regression dilution bias","volume":"340","author":"Hutcheon","year":"2010","journal-title":"BMJ."},{"issue":"4","key":"2021112516212957200_B26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ng.548","article-title":"Variance component model to account for sample structure in genome-wide association studies","volume":"42","author":"Kang","year":"2010","journal-title":"Nat Genet."},{"issue":"2","key":"2021112516212957200_B27","first-page":"131","article-title":"Complement levels in cigarette smokers: elevation of serum concentrations of C5, C9, and C1-inhibitor","volume":"6","author":"Wyatt","year":"1981","journal-title":"J Clin Lab Immunol."},{"issue":"7","key":"2021112516212957200_B28","first-page":"4794","article-title":"A novel C5a receptor-tissue factor cross-talk in neutrophils links innate immunity to coagulation pathways","volume":"177","author":"Ritis","year":"2006"},{"issue":"3","key":"2021112516212957200_B29","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.4049\/jimmunol.155.3.1434","article-title":"Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1","volume":"155","author":"Kilgore","year":"1995","journal-title":"J Immunol."},{"issue":"5","key":"2021112516212957200_B30","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.thromres.2011.01.002","article-title":"Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism","volume":"127","author":"Campello","year":"2011","journal-title":"Thromb Res."},{"issue":"2","key":"2021112516212957200_B31","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1161\/01.ATV.15.2.258","article-title":"Venous thrombosis-associated inflammation and attenuation with neutralizing antibodies to cytokines and adhesion molecules","volume":"15","author":"Wakefield","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"issue":"6","key":"2021112516212957200_B32","first-page":"1593","article-title":"Changes in the levels of soluble adhesion molecules and coagulation factors in patients with deep vein thrombosis","volume":"82","author":"Smith","year":"1999","journal-title":"Thromb Haemost."},{"issue":"4","key":"2021112516212957200_B33","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1160\/TH11-09-0673","article-title":"Procoagulant activity of erythrocytes and platelets through phosphatidylserine exposure and microparticles release in patients with nephrotic syndrome","volume":"107","author":"Gao","year":"2012","journal-title":"Thromb Haemost."},{"issue":"6","key":"2021112516212957200_B34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med."},{"issue":"8","key":"2021112516212957200_B35","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.molimm.2004.09.028","article-title":"CRP after 2004","volume":"42","author":"Agrawal","year":"2005","journal-title":"Mol Immunol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/21\/2129\/1847958\/bloodbld2021010822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/138\/21\/2129\/1847958\/bloodbld2021010822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T06:36:44Z","timestamp":1672987004000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/138\/21\/2129\/476493\/Elevated-plasma-concentration-of-complement-factor"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,25]]},"references-count":35,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021,11,25]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2021010822","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,25]]}}}